Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

4AB:GR

53.800 EUR 1.592 2.87%

As of 10:02:57 ET on 01/30/2015.

Snapshot for AbbVie Inc (4AB)

Open: 56.315 Day's Range: 53.129 - 57.300 Volume: 6,805
Previous Close: 55.392 52wk Range: 32.570 - 59.270 1-Yr Rtn: +51.87%

Stock Chart for 4AB

No chart data available.
  • 4AB:GR 54.337
  • 1D
  • 1M
  • 1Y
55.392
Interactive 4AB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4AB

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 13.6901
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 4.4360
Est. PEG Ratio 1.3934
Market Cap (M EUR) 85,727.71
Shares Outstanding (M) 1,593.45
30 Day Average Volume 1,974
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.11%
Cash Dividend (USD) 0.4900
Dividend Ex-Date 01/13/2015
5 Year Dividend Growth -
Next Earnings Announcement 04/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4AB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 4AB

AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.

Richard A Gonzalez "Rick"Chairman/CEOWilliam J ChaseExec VP/CFO
Michael Severino "Mike"Exec VP:Research & DevelopmentLaura J SchumacherExec VP:Bus Dev/Secy /Gen Cnsl
More Company Profile & Key Executives for 4AB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil